Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Hemoglobin A1c (HbA1c) is a stable compound, which is an important indicator for diagnosing glycemia, evaluating blood glucose control in patients with diabetes, and guiding the formulation of treatment plans. However, the detection of HbA1c is easily affected by many factors, resulting in a false increase or decrease, which affects the accuracy of test results.

Methods: In this paper, two abnormal HbA1c results were detected in the laboratory, which did not match the blood glucose detected at the same time. We adopted different detection systems to detect and proved that interference by different factors was observed in the results of glycosylated hemoglobin detection.

Results: When the HbA1c results are abnormal or inconsistent with clinical symptoms, the inspection staff should find the problem in time and retest with different detection systems to confirm results or obtain the corrected results.

Conclusions: HbA1c has been included in the diagnostic criteria of diabetes, as a routine test in laboratory. The laboratory staff should understand the characteristics and influencing factors of the HbA1c detection method in our laboratory, carefully observe the HbA1c map and query the patient case data, and find and solve problems, so as to provide more accurate reports for the clinic and better serve the clinic.

Download full-text PDF

Source
http://dx.doi.org/10.7754/Clin.Lab.2025.250201DOI Listing

Publication Analysis

Top Keywords

hemoglobin a1c
8
blood glucose
8
detection systems
8
hba1c
7
cases abnormal
4
abnormal hemoglobin
4
a1c background
4
background hemoglobin
4
a1c hba1c
4
hba1c stable
4

Similar Publications

Insulin therapy remains a cornerstone in the management of type 2 diabetes mellitus (T2DM), especially in patients experiencing progressive loss of pancreatic beta-cell function or those with inadequate glycemic control despite oral antidiabetic therapy. This review synthesized clinical outcomes from 44 peer-reviewed case reports published between 2019 and 2024, identified through systematic searches in PubMed and Scopus. The included cases involved 15 males and 29 females, with patient ages ranging from 11 to 91 years (mean 53 ± 20.

View Article and Find Full Text PDF

Background: Patients with type 2 diabetes mellitus (T2DM) often experience hypoglycemia, an underappreciated consequence that has a major negative influence on treatment compliance and quality of life.

Objective: This study aimed to determine the prevalence and associated factors of hypoglycemia among patients with T2DM, with a focus on treatment types, comorbidities, and glycemic control. By providing population-specific data, the study intends to inform clinical decision-making and contribute to safer, more personalized diabetes management strategies.

View Article and Find Full Text PDF

Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are established treatments for obesity. However, it remains inconclusive whether the combination of lifestyle modifications and GLP-1RA interventions can lead to greater weight loss and better control of cardiovascular biomarkers. We aimed to evaluate the efficacy of this combination therapy on weight loss and cardiometabolic markers in adults with overweight or obesity.

View Article and Find Full Text PDF

There is a lack of longitudinal data on type 2 diabetes (T2D) in low- and middle-income countries. We leveraged the electronic health records (EHR) system of a publicly funded academic institution to establish a retrospective cohort with longitudinal data to facilitate benchmarking, surveillance, and resource planning of a multi-ethnic T2D population in Malaysia. This cohort included 15,702 adults aged ≥ 18 years with T2D who received outpatient care (January 2002-December 2020) from Universiti Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia.

View Article and Find Full Text PDF

Increased adiposity and chronic psychosocial stress (CPS) are plausible modifiable contributors of the recent increase in early-onset colorectal cancer (EOCRC). We conducted an 8-week randomized controlled pilot trial evaluating the feasibility and acceptability of time restricted eating (TRE) (daily ad libitum eating between 12-8pm) and Mindfulness ("Mindfulness for Beginners" course from the Calm app) among young adults. Participants were randomized to the following groups: TRE ( = 10); Mindfulness ( = 11); TRE & Mindfulness ( = 11); or Control ( = 11).

View Article and Find Full Text PDF